Drug retention after intradiscal administration

Intradiscal drug delivery is a promising strategy for treating intervertebral disk degeneration (IVDD). Local degenerative processes and intrinsically low fluid exchange are likely to influence drug retention. Understanding their connection will enable the optimization of IVDD therapeutics. Release...

Full description

Saved in:
Bibliographic Details
Main Authors: Imke Rudnik-Jansen, Jie Du, Nina Karssemakers-Degen, Anna R. Tellegen, Parvesh Wadhwani, Daniele Zuncheddu, Björn P. Meij, Jens Thies, Pieter Emans, Fetullah C. Öner, George Mihov, Joao Pedro Garcia, Anne S. Ulrich, Sibylle Grad, Marianna A. Tryfonidou, Hugo van Ingen, Laura B. Creemers
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Drug Delivery
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/10717544.2024.2415579
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850138917613862912
author Imke Rudnik-Jansen
Jie Du
Nina Karssemakers-Degen
Anna R. Tellegen
Parvesh Wadhwani
Daniele Zuncheddu
Björn P. Meij
Jens Thies
Pieter Emans
Fetullah C. Öner
George Mihov
Joao Pedro Garcia
Anne S. Ulrich
Sibylle Grad
Marianna A. Tryfonidou
Hugo van Ingen
Laura B. Creemers
author_facet Imke Rudnik-Jansen
Jie Du
Nina Karssemakers-Degen
Anna R. Tellegen
Parvesh Wadhwani
Daniele Zuncheddu
Björn P. Meij
Jens Thies
Pieter Emans
Fetullah C. Öner
George Mihov
Joao Pedro Garcia
Anne S. Ulrich
Sibylle Grad
Marianna A. Tryfonidou
Hugo van Ingen
Laura B. Creemers
author_sort Imke Rudnik-Jansen
collection DOAJ
description Intradiscal drug delivery is a promising strategy for treating intervertebral disk degeneration (IVDD). Local degenerative processes and intrinsically low fluid exchange are likely to influence drug retention. Understanding their connection will enable the optimization of IVDD therapeutics. Release and retention of an inactive hydrophilic fluorine-19 labeled peptide (19F-P) as model for regenerative peptides was studied in a whole IVD culture model by measuring the 19F-NMR (nuclear magnetic resonance) signal in culture media and IVD tissue extracts. In another set-up, noninvasive near-infrared imaging was used to visualize IR-780, as hydrophobic small molecular drug model, retention upon injection into healthy and degenerative caudal IVDs in a rat model of disk degeneration. Furthermore, IR-780-loaded degradable polyester amide microspheres (PEAM) were injected into healthy and needle pricked degenerative IVDs, subcutaneously, and in knee joints with and without surgically-induced osteoarthritis (OA). Most 19F-P was released from the IVD after 7 days. IR-780 signal intensity declined over a 14-week period after bolus injection, without a difference between healthy and degenerative disks. IR-780 signal declined faster in the skin and knee joints compared to the IVDs. IR-780 delivery by PEAMs enhanced disk retention beyond 16 weeks. Moreover, in degenerated IVDs the IR-780 signal was higher over time than in healthy IVDs while no difference between OA and healthy joints was noted. We conclude that the clearance of peptides and hydrophobic small molecules from the IVD is relatively fast. These results illustrate that development of controlled release formulations should take into account the target anatomical location and local (patho)biology.
format Article
id doaj-art-e74ff26b3ae344bf99b69a5fc7b3d7c3
institution OA Journals
issn 1071-7544
1521-0464
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Drug Delivery
spelling doaj-art-e74ff26b3ae344bf99b69a5fc7b3d7c32025-08-20T02:30:28ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642024-12-0131110.1080/10717544.2024.2415579Drug retention after intradiscal administrationImke Rudnik-Jansen0Jie Du1Nina Karssemakers-Degen2Anna R. Tellegen3Parvesh Wadhwani4Daniele Zuncheddu5Björn P. Meij6Jens Thies7Pieter Emans8Fetullah C. Öner9George Mihov10Joao Pedro Garcia11Anne S. Ulrich12Sibylle Grad13Marianna A. Tryfonidou14Hugo van Ingen15Laura B. Creemers16Department of Orthopedics, University Medical Center Utrecht, Utrecht, The NetherlandsDepartment of Orthopedics, University Medical Center Utrecht, Utrecht, The NetherlandsDSM Biomedical, Geleen, The NetherlandsDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The NetherlandsInstitute of Biological Interfaces (IBG2) and Institute of Organic Chemistry (IOC), Karlsruhe Institute of Technology (KIT), Karlsruhe, GermanyAO Research Institute Davos, Davos, SwitzerlandDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The NetherlandsDSM Biomedical, Geleen, The NetherlandsDepartment of Orthopaedics, Maastricht University Medical Center, Joint-Preserving Clinic Maastricht, The NetherlandsDepartment of Orthopedics, University Medical Center Utrecht, Utrecht, The NetherlandsDSM Biomedical, Geleen, The NetherlandsDepartment of Orthopedics, University Medical Center Utrecht, Utrecht, The NetherlandsInstitute of Biological Interfaces (IBG2) and Institute of Organic Chemistry (IOC), Karlsruhe Institute of Technology (KIT), Karlsruhe, GermanyAO Research Institute Davos, Davos, SwitzerlandDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The NetherlandsNMR Group, Bijvoet Centre for Biomolecular Research, Utrecht University, Utrecht, The NetherlandsDepartment of Orthopedics, University Medical Center Utrecht, Utrecht, The NetherlandsIntradiscal drug delivery is a promising strategy for treating intervertebral disk degeneration (IVDD). Local degenerative processes and intrinsically low fluid exchange are likely to influence drug retention. Understanding their connection will enable the optimization of IVDD therapeutics. Release and retention of an inactive hydrophilic fluorine-19 labeled peptide (19F-P) as model for regenerative peptides was studied in a whole IVD culture model by measuring the 19F-NMR (nuclear magnetic resonance) signal in culture media and IVD tissue extracts. In another set-up, noninvasive near-infrared imaging was used to visualize IR-780, as hydrophobic small molecular drug model, retention upon injection into healthy and degenerative caudal IVDs in a rat model of disk degeneration. Furthermore, IR-780-loaded degradable polyester amide microspheres (PEAM) were injected into healthy and needle pricked degenerative IVDs, subcutaneously, and in knee joints with and without surgically-induced osteoarthritis (OA). Most 19F-P was released from the IVD after 7 days. IR-780 signal intensity declined over a 14-week period after bolus injection, without a difference between healthy and degenerative disks. IR-780 signal declined faster in the skin and knee joints compared to the IVDs. IR-780 delivery by PEAMs enhanced disk retention beyond 16 weeks. Moreover, in degenerated IVDs the IR-780 signal was higher over time than in healthy IVDs while no difference between OA and healthy joints was noted. We conclude that the clearance of peptides and hydrophobic small molecules from the IVD is relatively fast. These results illustrate that development of controlled release formulations should take into account the target anatomical location and local (patho)biology.https://www.tandfonline.com/doi/10.1080/10717544.2024.2415579Drug retentionpeptidesmall moleculepolyester amide microsphereintervertebral disk degeneration
spellingShingle Imke Rudnik-Jansen
Jie Du
Nina Karssemakers-Degen
Anna R. Tellegen
Parvesh Wadhwani
Daniele Zuncheddu
Björn P. Meij
Jens Thies
Pieter Emans
Fetullah C. Öner
George Mihov
Joao Pedro Garcia
Anne S. Ulrich
Sibylle Grad
Marianna A. Tryfonidou
Hugo van Ingen
Laura B. Creemers
Drug retention after intradiscal administration
Drug Delivery
Drug retention
peptide
small molecule
polyester amide microsphere
intervertebral disk degeneration
title Drug retention after intradiscal administration
title_full Drug retention after intradiscal administration
title_fullStr Drug retention after intradiscal administration
title_full_unstemmed Drug retention after intradiscal administration
title_short Drug retention after intradiscal administration
title_sort drug retention after intradiscal administration
topic Drug retention
peptide
small molecule
polyester amide microsphere
intervertebral disk degeneration
url https://www.tandfonline.com/doi/10.1080/10717544.2024.2415579
work_keys_str_mv AT imkerudnikjansen drugretentionafterintradiscaladministration
AT jiedu drugretentionafterintradiscaladministration
AT ninakarssemakersdegen drugretentionafterintradiscaladministration
AT annartellegen drugretentionafterintradiscaladministration
AT parveshwadhwani drugretentionafterintradiscaladministration
AT danielezuncheddu drugretentionafterintradiscaladministration
AT bjornpmeij drugretentionafterintradiscaladministration
AT jensthies drugretentionafterintradiscaladministration
AT pieteremans drugretentionafterintradiscaladministration
AT fetullahconer drugretentionafterintradiscaladministration
AT georgemihov drugretentionafterintradiscaladministration
AT joaopedrogarcia drugretentionafterintradiscaladministration
AT annesulrich drugretentionafterintradiscaladministration
AT sibyllegrad drugretentionafterintradiscaladministration
AT mariannaatryfonidou drugretentionafterintradiscaladministration
AT hugovaningen drugretentionafterintradiscaladministration
AT laurabcreemers drugretentionafterintradiscaladministration